Celularity Inc. (CELU)
NASDAQ: CELU · Real-Time Price · USD
1.310
-0.020 (-1.50%)
At close: Apr 1, 2026, 4:00 PM EDT
1.340
+0.030 (2.29%)
After-hours: Apr 1, 2026, 7:50 PM EDT
Celularity Market Cap
Celularity has a market cap or net worth of $37.78 million as of April 1, 2026. Its market cap has increased by 12.76% in one year.
Market Cap
37.78M
Enterprise Value
104.42M
1-Year Change
12.76%
Ranking
Category
Stock Price
$1.31
Market Cap Chart
Since August 8, 2019, Celularity's market cap has decreased from $352.19M to $37.78M, a decrease of -89.27%. That is a compound annual growth rate of -28.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2026 | 38.35M | 21.33% |
| Dec 31, 2025 | 31.61M | -32.41% |
| Dec 31, 2024 | 46.77M | -1.00% |
| Dec 29, 2023 | 47.24M | -74.75% |
| Dec 30, 2022 | 187.07M | -70.41% |
| Dec 31, 2021 | 632.14M | 59.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Aug 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nutriband | 42.91M |
| Lite Strategy | 42.18M |
| Werewolf Therapeutics | 40.46M |
| Sensei Biotherapeutics | 39.89M |
| NovaBay Pharmaceuticals | 39.67M |
| Atara Biotherapeutics | 38.68M |
| NextCure | 38.03M |
| Palatin Technologies | 36.77M |